Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results Meeting Abstract
| Authors: | Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V. |
| Abstract Title: | Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results |
| Meeting Title: | 44th Annual Conference of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 59 |
| Issue: | 6 |
| Meeting Dates: | 2012 Oct 5-8 |
| Meeting Location: | London, United Kingdom |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2012-12-01 |
| Start Page: | 1057 |
| Language: | English |
| ACCESSION: | WOS:000309754300369 |
| PROVIDER: | wos |
| PUBMED: | 22987436 |
| DOI: | 10.1002/pbc.24295 |
| Notes: | --- - Meeting Abstract: PH022 - SI - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
